Improving awareness, understanding, and enforcement of responsibilities and regulations in Blue Biotechnology

Schneider, Xenia T.; Stroil, Belma K.; Tourapi, Christiana; Rebours, Céline; Novoveska, Lucie; Vasquez, Marlen I.; Gaudêncio, Susana P.

http://hdl.handle.net/10362/162645

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
1-s2.0-S0167779923001580-main.pdf		1.47 MB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Resumo(s)

Blue Biotechnology is developing rapidly worldwide. However, the Nagoya Protocol (NP), Responsible Research and Innovation (RRI) and other regulatory requirements in this field are falling behind. This article identifies the main RRI, NP, and regulatory gaps and provides key recommendations to mitigate these challenges.

Descrição

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. This publication is based upon work from COST Action CA18238 (Ocean4Biotech), funded by the European Cooperation in Science and Technology (COST) Program in the period 2019–2023. The work of Kalamujić Stroil B. and Tourapi C. was co-funded by the COST Action CA18238 through Virtual Mobility grants. This work is also financed by the Research Council of Norway (319577SAFERIMTA, 326803SUSKELPFOOD, 294946SBP-N) and Møreforsking AS